Skip to main content
Log in

Reversal of defective G-proteins and adenylyl cyclase/cAMP signal transduction in diabetic rats by vanadyl sulphate therapy

  • Part II: Biochemical and Physiological Studies
  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Vanadium salts exhibit a wide variety of insulinomimetic effects. In the present studies, we have examined the modulation of G-protein levels and adenylyl cyclase activity in the liver of streptozotocin-induced chronic diabetic rats (STZD) by vanadyl sulfate treatment and compared it with that of insulin. The basal enzyme activity, as well as the stimulatory effects of guanine nucleotides, glucagon, N-Ethylcarboxamideadenosine (NECA), isoproterenol, forskolin and sodium fluoride (NaF) on adenylyl cyclase were significantly increased in STZ-D rat liver as compared to control. In addition, the levels of stimulatory (Gsα) as well as inhibitory (Giα-2 and Giα-3) as determined by immunoblotting techniques were also significantly higher in the STZ-D rat liver, however, the inhibitory effects of oxotremorine and low concentration of GTPγS on adenylyl cyclase were not different in the two groups. Vanadyl sulfate and insulin treatments restored the augmented basal enzyme activity, the stimulations exerted by stimulatory inputs on adenylyl cyclase and the G-protein levels to various degrees, however, vanadyl sulfate was more effective than insulin. In addition, unlike vanadyl sulfate, insulin was unable to improve the stimulation exerted by glucagon and isoproterenol on adenylyl cyclase activity in STZD rats. These results suggest that vanadyl sulfate mimics the effects of insulin to restore the defective levels of G-proteins and adenylyl cyclase activity. From these results it may be suggested that one of the mechanisms by which vanadyl sulfate improves the glucose homeostasis in STZ-D rats may be through its ability to modulate the levels of G-proteins and adenylyl cyclase signal transduction system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

NECA:

N-ethylcarboxamideadenosine

Iso:

Isoproterenol

Glu:

Glucagon

FSK:

forskolin

GTPγS:

guanosine 5′-[γ-thio]triphosphate

Gs:

stimulatory guanine nucleotide regulatory protein

Gi:

inhibitory guanine nucleotide regulatory protein

STZ:

streptozotocin

References

  1. Lunch CJ, Blackmore PF, Johnson EH, Wange RL, Krone PK, Exton JH: Guanine nucleotide binding regulatory proteins and adenylate cyclase in livers of streptozotocin- and BB/Wor-diabetic rats. Immunodetection of Gs and Gi with antisera prepared against synthetic peptides. J Clin Invest 83: 2050–2062, 1989

    Google Scholar 

  2. Bushfield M, Griffiths SL, Strassheim D, Tang E, Shakur Y, Lavan B, Houslay MD: Guanine-nucleotide-binding proteins in diabetes and insulin-resistant states. Biochem Soc Symp 56: 137–154, 1990

    Google Scholar 

  3. Gilman AG: G-protein and dual control of adenylate cyclase. Cell 36: 577–579, 1984

    Google Scholar 

  4. Gilman AG: G-proteins: transducers of receptor-generated signals. Ann Rev Biochem 56: 615–649, 1987

    Google Scholar 

  5. Stryer L, Bourne HR: G-proteins: a family of signal transducers. Ann Rev Cell Biol 2: 391–419, 1986

    Google Scholar 

  6. Sternweis PC, Northup JK, Smigel MD, Gilman AG: The regulatory component of adenylate cyclase. J Biol Chem 256: 11517–11526, 1981

    Google Scholar 

  7. Murakami T, Yasuda H: Rat heart cell membranes contain three substrates for cholera toxin-catalyzed ADP-ribosylation and a single substrate for pertussis toxin-catalyzed ADP-ribosylation. Biochem Biophys Res Commun 138: 1355–1361, 1986

    Google Scholar 

  8. Robishaw JD, Smigel MD, Gilman AG: Molecular basis for two forms of the G-protein that stimulates adenylyl cyclase. J Biol Chem 261: 9587–9590, 1986

    Google Scholar 

  9. Bray P, Caster A, Simons C, Guo V, Puckett C, Hamholz J, Spiegel A, Nirenberg H: Human cDNA clones for four species of Gsα signal transduction protein. Proc Natl Acad Sci USA 83: 8893–8897, 1986

    Google Scholar 

  10. Itoh H, Kozaka T, Magata S, Nakamura S, Katada T, Ui M, Iwai S Ohtsuka E, Kawasaki H, Suzuki K, Kaziro Y: Molecular cloning and sequence determination of cDNAs for a subunits of the guanine nucleotide-binding proteins Gs, Gi and Go from brain. Proc Natl Acad Sci USA 83: 3776–3780, 1986

    Google Scholar 

  11. Jones DT, Reed RR: Molecular cloning of five GTP-binding protein cDNA species from rat olfactory neuroepithelium. J Biol Chem 262: 14241–14249, 1987

    Google Scholar 

  12. Itoh H, Toyama R, Kozasa T, Tsukamoto T, Matsuoka M, Kaziro Y: Presence of three distinct molecular species of Gi protein: a subunit structure of rat cDNA and human genomic DNAs. J Biol Chem 263: 6656–6664, 1988

    Google Scholar 

  13. Kirkham DM, Murphy CJ, Yong Y: Demonstration of inhibitory guanine nucleotide regulatory protein (Gi) function in liver and hepatocyte membranes from streptozotocin-treated rats. Biochem J 284: 301–304, 1992

    Google Scholar 

  14. Allard WJ, Vicasio PP, Saperstein R, Slater EE, Strout HV: The functions but not the expression of rat liver inhibitory guanine nucleotides binding protein is altered in streptozotocin-induced diabetes. Endocrinology 129: 169–175, 1991

    Google Scholar 

  15. Tolman EL, Barris E, Burns M, Pansini A, Partridge R: Effects of vanadium on glucose metabolismin vitro. Life Sci 25: 1159–1164, 1979

    Google Scholar 

  16. Shechter Y, Karlish SJD: Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl ions (IV) ions. Nature 284: 556–558, 1980

    Google Scholar 

  17. Shechter Y: Insulin mimetic effects of vanadate possible implications for future treatment of diabetes. Diabetes 39: 1–5, 1990

    Google Scholar 

  18. Heyliger CE, Tahiliani AG, McNeill JH: Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 227: 1474–1477, 1985

    Google Scholar 

  19. Bendayan M, Gingras D: Effect of vanadate administration on blood glucose and insulin levels as well as on exocrine pancreatic function in streptozotocin-diabetic rats. Diabetologia 32: 561–567, 1989

    Google Scholar 

  20. Ramandham S, Mongold JJ, Browsey W, Cros GH, McNeill JH: Oral vanadyl sulphate in treatment of diabetes mellitus in rats. Am J Physiol 257: 11904–11911, 1989

    Google Scholar 

  21. Pederson RA, Ramadaham S, Buchan AMJ, McNeill JH: Long term effects on vanadyl treatment on streptozotocin-induced diabetes in rats. Diabetes 38: 1390–1395, 1989

    Google Scholar 

  22. Erickson JW, Lonnroth P, Smith U: Vanadate increases cell surface insulin binding and improves insulin sensitivity in both normal and insulin-resistant adipocytes. Diabetologia 35: 510–516, 1992

    Google Scholar 

  23. Mooney RA, Boodwell KL, Luhowskyj S, Casneillie JE: The insulin-like effect of vanadate on lipolysis in rat adipocytes is not accompanied by an insulin-like effect on tyrosine phosphorylation. Endocrinology 124: 422–429, 1989

    Google Scholar 

  24. Strout HV, Vicario P, Saperstein R, Slater EE: The insulin-mimetic effect of vanadate is not correlated with insulin receptor tyrosine kinase activity nor phosphorylation in mouse diaphragmsin vivo. Endocrinology 124: 1918–1924, 1989

    Google Scholar 

  25. Eckel J, Gerlack-Eskchen E, Reinauer H: G-protein mediated regulation of the insulin-responsive glucose transporter in isolated cardiac myocytes. Biochem J 272: 691–696, 1990

    Google Scholar 

  26. Srivastava AK, Srivastava MB: Streptozotocin-induced diabetes and hormone sensitivity of adenylate cyclase in rat myocardial sarcolemma, aorta and liver. Biochem Pharmacol 34: 2013–2017, 1985

    Google Scholar 

  27. Anand-Srivastava MB: Enhanced expression of inhibitory guanine nucleotide regulatory protein in spontaneously hypertensive rats: relationship to adenylate cyclase inhibition. Biochem J 288: 79–85 1992

    Google Scholar 

  28. Anand-Srivastava MB: Platelets from spontaneously hypertensive rats exhibit decreased expression of inhibitory guanine nudeotide regulatory protein; relation with adenylyl cyclase activity. Circ Res 73: 1032–1039, 1993

    Google Scholar 

  29. Salomon Y, Londos C, Rodbell M: A highly sensitive adenylate cyclase assay. Anal Biochem 58: 541–548, 1974

    Google Scholar 

  30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275, 1951

    Google Scholar 

  31. Thibault C, Anand-Srivastava MB: Altered expression of G-protein mRNA in spontaneously hypertensive rats. FEBS Lett 313: 160–164, 1992

    Google Scholar 

  32. Anand-Srivastava MB, de Champlain J, Thibault C: DOCA-salt hypertensive rat hearts exhibit altered expression of G-proteins. Am J Hypertens 6: 72–75, 1993

    Google Scholar 

  33. Wei JW, Wang MC: Muscarinic M2 receptors coupled to inhibition of adenylate cyclase in rat heart. Chinese J Physiol 33: 315–326, 1990

    Google Scholar 

  34. Bushfield M, Griffiths SL, Murphy GJ, Pyne NJ, Knowler JT, Milligan G, Parker PJ, Mollner S, Houslay MD: Diabetes-induced alterations in the expression, functioning and phosphorylation state of the inhibitory guanine nucleotide regulatory protein Gi-2 in hepatocytes. Biochem J 271: 365–372, 1990

    Google Scholar 

  35. Griffiths SL, Knowler JT, Houslay MD: Diabetes-induced changes in guanine nucleotide-regulatory protein mRNA detected using synthetic oligonucleotide probes. Eur J Biochem 193: 367–374, 1990

    Google Scholar 

  36. Bachmann W, Bottger I, Allgayer H, Haslbeck M, Hepp KD: [Insulin, glucagon binding and adenylate cyclase activity of liver plasma membranes in streptozotocin-diabetic rats] (trans.). Verhandlungen Deutschen Gesellschaft Inn Med 84: 1217–1220, 1978

    Google Scholar 

  37. Srikant CB, Freeman D, McCorkle K, Unger RH: Binding and biological activity of glucagon in liver cell membranes of chronically hyperglucagonemic rats. J Biol Chem 252: 7434–7436, 1977

    Google Scholar 

  38. Bhathena SJ, Voyles NR, Smith S, Recant L: Decreased glucagon receptors in diabetic rat hepatocytes. Evidence for regulation of glucagon receptors by hyperglucagonemia. J Clin Invest 51: 1488–1497, 1978

    Google Scholar 

  39. Krupinski J, Lehman TC, Prankenfield CD, Zwaagstra JC, Watson PA: Molecular diversity in the diversity in the adenylyl cyclase family: evidence for eight forms of the enzyme and cloning of type VI. J Biol Chem 267: 24858–24862, 1992

    Google Scholar 

  40. Hilderbrandt JD, Hanoune J, Birnbaumer J: Guanine nucleotide inhibition of Cyc 549 mouse lymphoma cell membrane adenylyl cyclase. 257: 14723-14725, 1982

  41. Heyworth CM, Houslay MD: Insulin exerts actions through a distinct species of guanine nucleotide regulatory protein: inhibition of adenylyl cyclase. Biochem J 214: 547–552, 1983

    Google Scholar 

  42. Green A, Johnson JL: Evidence for impaired coupling of receptor to Gi protein in adipocytes from streptozotocin-induced diabetic rats. Diabetes 40: 89–94, 1991

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported by grants from Medical Research Council and Canadian Diabetes Association.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anand-Srivastava, M.B., McNeill, J.H. & Yang, XP. Reversal of defective G-proteins and adenylyl cyclase/cAMP signal transduction in diabetic rats by vanadyl sulphate therapy. Mol Cell Biochem 153, 113–119 (1995). https://doi.org/10.1007/BF01075925

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01075925

Key words

Navigation